Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
05/1996
05/14/1996US5516757 Antifungal
05/14/1996US5516756 Microbiocides
05/14/1996US5516755 Antitumor and antibacterial peptide and methods of use
05/14/1996US5516643 Diagnosis
05/09/1996WO1996013607A1 Compositions for the detection of proteases in biological samples and methods of use thereof
05/09/1996WO1996013517A1 Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
05/09/1996WO1996013272A1 Aza cyclohexapeptide compounds
05/09/1996WO1996013161A1 Creating an aerosolized formulation of insulin
05/09/1996CA2203641A1 Bcl-x/bcl-2 associated cell death regulator
05/09/1996CA2202920A1 Aza cyclohexapeptide compounds
05/09/1996CA2201703A1 New sequences of hepatitis c virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
05/09/1996CA2173874A1 Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
05/08/1996EP0710247A1 Process for manufacture of 1-deamino-8-d-arginine vasopressin
05/08/1996EP0710246A1 Thrombin receptor radioligands and assays for identifying thrombin receptor antagonists
05/08/1996EP0710243A1 Improved synthesis of cyclic peptides
05/08/1996EP0710228A1 Hydrazino-type radionuclide chelators having an n 3?s configuration
05/08/1996EP0642524A4 Systemin.
05/08/1996EP0517778B1 Vasoactive vasotocin derivatives
05/08/1996EP0365646B1 Synthetic peptides from streptococcal m protein and vaccines prepared therefrom
05/07/1996US5514774 Conotoxin peptides
05/07/1996US5514651 Aza cyclohexapeptide compounds
05/07/1996US5514650 Pneumocystis fungicide
05/07/1996US5514648 Fungicidally active compounds
05/07/1996US5514409 Methods for coating invasive devices with inhibitors of thrombin
05/07/1996CA1338319C Cyclosporin derivative with modified "8-amino acid"
05/02/1996WO1996012964A1 Receptor for a bacillus thuringiensis toxin
05/02/1996WO1996012809A2 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
05/02/1996WO1996012738A2 Pepstatin-derivatives for the treatment and detection of fungal infections
05/02/1996WO1996012737A2 Compositions and treatment for multiple sclerosis
05/02/1996WO1996012732A1 Novel peptide and therapeutic agent
05/02/1996WO1996012731A1 Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients
05/02/1996WO1996012499A1 Amidino and guanidino substituted inhibitors of trypsin-like enzymes
05/02/1996CA2652992A1 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
05/02/1996CA2203629A1 Compositions and treatment for multiple sclerosis
05/02/1996CA2203018A1 Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients
05/02/1996CA2200427A1 Receptor for a bacillus thuringiensis toxin
05/01/1996EP0708784A1 COMPOUNDS HAVING THE ANTIGENICITY OF hCG
05/01/1996EP0708656A1 Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
05/01/1996EP0708654A1 THF-$g(g)2 ANALOGS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
05/01/1996CN1121709A Oxytocin antagonist
04/1996
04/30/1996US5512550 Method for inhibiting angiogenesis with modified platelet factor-4 and cleaved platelet factor-4
04/30/1996CA1338301C Therapeutic octapeptide somatostatin analogs
04/25/1996WO1996012032A1 Process for manufacturing cyclosporin a by highly productive fusant strain
04/25/1996WO1996012031A1 Process for preparing cyclosporin a
04/25/1996WO1996012019A2 Her4 human receptor tyrosine kinase or the epidermal growth factor receptor family
04/25/1996WO1996011948A1 Neurotrophic peptides of activity dependent neurotrophic factor
04/25/1996WO1996011944A1 Synthetic peptides and vaccines comprising same
04/25/1996WO1996011943A1 New peptides with immunomodulatory effects
04/25/1996CA2202533A1 Her4 human receptor tyrosine kinase
04/25/1996CA2201479A1 New peptides with immunomodulatory effects
04/24/1996EP0707595A1 Peptidase resistant thrombin receptor peptide ligand
04/24/1996EP0707488A1 Cyclohexapeptidyl amine compounds
04/24/1996EP0489070B1 Novel inhibitors of thrombin
04/24/1996EP0429626B1 Synthetic peptides for use in vivo in thrombus detection
04/23/1996US5510460 Peptide process
04/23/1996US5510333 Inhibitors of Cathepsin G and elastase for preventing connective tissue degradation
04/23/1996US5510331 Antihypertensive peptides
04/23/1996US5510270 Generating pattern of light and dark areas by selectively irradiating surface areas; deprotecting; contacting with receptor to identify oligonucleotide showing complementarity to receptor
04/23/1996US5510240 Method of screening a peptide library
04/19/1996CA2138425A1 Neuronal apoptosis inhibitor protein, gene sequence and mutations causative of spinal muscular atrophy
04/18/1996WO1996011270A1 Cloning and characterizing of genes associated with long-term memory
04/18/1996WO1996011214A1 Peptides and pharmaceutical compositions comprising them
04/18/1996WO1996011210A1 Cyclic hexapeptides having antibiotic activity
04/18/1996CA2201935A1 Peptides and pharmaceutical compositions comprising them
04/17/1996EP0706657A1 Inhibiting protein interactions
04/17/1996EP0506826B1 Antibody antagonists of human interleukin-4
04/17/1996EP0290565B1 Vaccine containing tick antigens
04/16/1996US5508383 Cyclic peptide LHRH antagonists
04/16/1996US5508382 Synthetic calcitonin
04/16/1996US5508264 Synergistic combinations of a cryif chimeric and cryia(c) chimeric bacillus thuringiensis delta-endotoxin; for controlling lepidopteran pests
04/16/1996US5508020 Technetium-99M labeled peptides for imaging
04/11/1996WO1996010634A1 Inhibitor of stem cell proliferation and uses thereof
04/11/1996WO1996010577A1 Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof
04/11/1996WO1996010414A1 Trophinin and trophinin-assisting proteins
04/11/1996CA2201506A1 Novel protein marker and dna encoding same
04/11/1996CA2201119A1 Trophinin and trophinin-assisting proteins
04/10/1996EP0705841A1 Peptides havng antigenic activity against hepatitis A virus (HAV)
04/10/1996EP0705343A1 Synthetic antifungal peptides
04/10/1996EP0705339A1 Human cell adhesion protein aamp-1 and uses thereof
04/10/1996EP0705274A1 Method and composition for treating thrombosis
04/10/1996EP0705105A1 Metal chelates as spacer compounds in biologically active peptides
04/09/1996US5506208 Method for using synthetic analogs of thrombospondin for inhibiting angiogenesis activity
04/09/1996US5506207 GNRH antagonists XIII
04/09/1996US5506206 Arginine-proline-hydroxyproline-glycine-thienylalanine-serine -(4-methyl-tyrosine)-arganine or a conformational analogue, used as therapeutical or diagnostic agents
04/09/1996US5506204 Muramyl compounds for treatment of septic shock
04/09/1996US5506134 Hypridoma and monoclonal antibody which inhibits blood coagulation tissue factor/factor VIIa complex
04/09/1996US5506121 Fusion peptides with binding activity for streptavidin
04/04/1996WO1996010040A1 Polypeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone
04/04/1996WO1996010038A1 Multifunctional molecular complexes for gene transfer to cells
04/04/1996DE4433572A1 New metal complexes of cyclic peptide(s), esp. with aspartic acid units
04/04/1996DE4433564A1 New metal complexes of linear peptide(s)
04/04/1996CA2201122A1 Polypeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone
04/03/1996EP0703924A1 Biologically active vasopressin analogues
04/03/1996EP0703900A1 PROCESS FOR THE PREPARATION OF PHENYLALANINE DERIVATIVES OR HOMOLOGUES CONTAINING A GUANIDINO OR MODIFIED GUANIDINO GROUP USEFUL FOR THE PREPARATION GnRH OF ANTAGONISTIC PEPTIDES
04/03/1996EP0703786A1 Use of nona- and decapeptides in the preparation of a drug for the treatment of aids
04/03/1996EP0703783A1 Hla-a2.1 binding peptides and their uses
04/03/1996CN1119650A Motilin-like polypeptides with gastrointestinal motor stimulating activity
04/02/1996US5504191 Human cancer inhibitory pentapeptide methyl esters
04/02/1996US5504190 Equimolar multiple oligomer mixtures, especially oligopeptide mixtures
04/02/1996US5504070 Inhibitors of the conversion of big endothelin to endothelin